Lotus Pharm vs Orient Pharma: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Orient Pharma (4166) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Orient Pharma

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYOrient PharmaYoY
Oct 2026NT$2.13 billion-22.5%NT$148 million-1.3%
Sep 2026NT$2.77 billion+128.0%NT$148.8 million+41.2%
Aug 2026NT$2.11 billion+81.7%NT$115.9 million+14.9%
Jul 2026NT$2.49 billion+3.9%NT$131.8 million+20.1%
Jun 2026NT$3.4 billion+225.5%NT$183 million+68.3%
May 2026NT$2.32 billion+105.8%NT$113 million-0.9%
Apr 2026NT$3.09 billion+19.9%NT$131 million+27.6%
Mar 2026NT$4.35 billion+173.6%NT$107.6 million+14.8%
Feb 2026NT$2.24 billion+131.5%NT$78.2 million-14.6%
Jan 2026NT$2.05 billion-5.5%NT$145.4 million+10.5%
Dec 2025NT$2.44 billion+66.9%NT$131.7 million+19.4%
Nov 2025NT$1.06 billion-0.2%NT$160 million+47.2%
Oct 2025NT$2.75 billion+46.0%NT$150 million+65.7%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16